Earnings Review · 16 November 2026
The print
Results are in but not yet verified against a primary source in our ledger; this review updates the moment the audited figures land. What does not change is our read below.
Did the flow confirm the move?
Underlying money flow is neutral (21-day Chaikin Money Flow -0.21, five-day price change +2.1%, as of 2026-11-13, desk flow model): no strong accumulation or distribution signature.
Give the business its due
The business itself is genuinely strong: revenue growing about -4%,
net margins near 13%, a weak competitive moat, backed by a 9%
return on equity.
Levels that matter
At $44.91 the shares sit 8% below the 52-week high of $48.79 and 30% above the low of $34.50 (73% of the way up the range). The 50-day average is $44.17, below the price. The 200-day average is $41.25, below the price.
The valuation lens
Our fair-value work puts the shares about 25% below what the business is worth: value on offer. Fair value lands near $56 against a $44.91 share price, a margin of safety of about 25%. The trailing multiple sits around 11 times earnings, which only makes sense if the growth holds.
The
ethical lens, our differentiator
Fails the principled screen, Business activity. A strong business is not the same as a suitable one; for a values-conscious book this is a do-not-chase regardless of the print.
The compliant alternative
There is no direct compliant equivalent in the same industry on our screen, the honest answer is to screen a step wider rather than reach for a false substitute.
The verdict for a values-conscious investor
A beat-and-raise does not change the screen. This is a great company you can admire without owning, protection first. One quarter, strong or soft, does not decide whether a holding is suitable.
This is analysis, not financial advice. Always manage your risk.